Pages that link to "Q36680074"

The following pages link to The application of siRNA technology to cancer biology discovery (Q36680074):

Displaying 13 items.

• Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library (Q33719287) (← links)
• Integrin alpha(v)beta(3)-Targeted Cancer Therapy (Q33983773) (← links)
• Significance and applications of nanoparticles in siRNA delivery for cancer therapy (Q34297263) (← links)
• Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer (Q34742858) (← links)
• Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation (Q36999094) (← links)
• Strategies for short hairpin RNA delivery in cancer gene therapy (Q37598928) (← links)
• Recent attempts at RNAi‐mediated P‐glycoprotein downregulation for reversal of multidrug resistance in cancer (Q37869444) (← links)
• Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. (Q39666717) (← links)
• siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma (Q40035650) (← links)
• Probing the binding of two sugar bearing anticancer agents aristololactam-β-(D)-glucoside and daunomycin to double stranded RNA polynucleotides: a combined spectroscopic and calorimetric study (Q44706456) (← links)
• A systematic study on the influence of thermodynamic asymmetry of 5'-ends of siRNA duplexes in relation to their silencing potency (Q64121914) (← links)
• Interaction of aristololactam-β-D-glucoside and daunomycin with poly(A): Spectroscopic and calorimetric studies (Q83582987) (← links)
• Editorial focus: understanding off-target effects as the key to successful RNAi therapy (Q92189125) (← links)